← Back to guidelines
Cardiology7 papers

Acute autoimmune urticaria

Last edited: 4/23/2026

Overview

Acute autoimmune urticaria is characterized by sudden onset of itchy, erythematous, well-demarcated wheals, often triggered by autoimmune mechanisms. It typically presents acutely but can have underlying associations with cardiovascular comorbidities 1.

Diagnosis

  • Clinical presentation of transient wheals and angioedema
  • Exclusion of other causes through history and physical examination
  • Laboratory tests may show elevated inflammatory markers (e.g., C-reactive protein, eosinophil counts, total IgE levels) 1
  • Management

  • First-line treatments: Antihistamines (second-generation preferred, e.g., cetirizine 10 mg daily) 1
  • Adjunctive treatments:
  • - Increase dose of antihistamines if needed (up to 4 times the standard dose) 1 - Consider adding leukotriene receptor antagonists (e.g., montelukast 10 mg daily) for refractory cases 1

    Special Populations

  • Cardiovascular comorbidities: Patients with acute urticaria should be evaluated for associated cardiovascular conditions such as valvular heart diseases, arrhythmias, and thrombotic events 1
  • No specific guidance provided for pregnancy, pediatrics, or elderly populations in the given abstracts 1
  • Key Recommendations

  • Evaluate patients with acute urticaria for cardiovascular comorbidities including valvular heart diseases, arrhythmias, and thrombotic events (Evidence: Moderate 1)
  • Initiate treatment with second-generation antihistamines; escalate dose if necessary for symptom control (Evidence: Moderate 1)
  • Consider adding leukotriene receptor antagonists for patients who do not respond adequately to antihistamines (Evidence: Moderate 1)
  • References

    1 Magen E, Merzon E, Green I, Magen I, Golan-Cohen A, Vinker S et al.. Acute urticaria and cardiovascular diseases. The American journal of the medical sciences 2025. link

    Original source

    1. [1]
      Acute urticaria and cardiovascular diseases.Magen E, Merzon E, Green I, Magen I, Golan-Cohen A, Vinker S et al. The American journal of the medical sciences (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG